Landscape Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Landscape Capital Management’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7,363	Closed	-$413K	–	895
2018 Q4	$413K	Buy	+7,363	New	+$450K	0.03%	527
2018 Q3	–	Sell	-21,113	Closed	-$738K	–	817
2018 Q2	$738K	Sell	21,113 -32,526	-61%	-$991K	0.06%	230
2018 Q1	$1.1M	Buy	53,639 +37,381	+230%	+$962K	0.08%	210
2017 Q4	$460K	Buy	16,258 +8,258	+103%	+$230K	0.04%	408
2017 Q3	$249K	Hold	8,000	–	–	0.03%	428
2017 Q2	$253K	Buy	+8,000	New	+$197K	0.03%	266

Other funds holding RETA

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Landscape Capital Management's RETA Position: Q1 2019 in Review

Landscape Capital Management sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q1 2019, closing a stake of 7,363 shares — an estimated $413K sold.

Landscape Capital Management first reported a position in RETA in Q2 2017 and held it in 6 quarters. The position peaked at $1.1M in Q1 2018. 157 funds tracked by Wall St. Rank hold RETA as of Q1 2019.

Landscape Capital Management reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q1 2019 after selling out during the quarter.
Landscape Capital Management sold 7,363 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q1 2019, an estimated $413K.
Landscape Capital Management first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2017 and held it in 6 quarters.
Landscape Capital Management's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $1.1M in Q1 2018.
157 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q1 2019.

Based on Landscape Capital Management's 13F filing for Q1 2019, filed 15 May 2019.